Results 21 to 30 of about 74,737 (254)

Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States

JAMA Network Open, 2023
This cohort study investigates the association of Ad26.COV2.S, BNT162b2, and mRNA-1273 COVID-19 vaccination with rates of Guillain-Barré syndrome among US adults.
W. Abara, J. Gee, P. Marquez, Jared Woo, T. Myers, Allison DeSantis, Jane Baumblatt, E. Woo, Deborah Thompson, N. Nair, John R. Su, T. Shimabukuro, D. Shay   +12 more
semanticscholar   +1 more source

Guillain-Barré Syndrome Associated with Acute HEV Hepatitis

Ibrahim Medical College Journal, 1970
Guillain-Barré Syndrome (GBS) otherwise known as Acute Inflammatory Polyneuritis, characterized by acute progressive limb weakness and aretlexia, is the prototype of a post infectious autoimmune disease. Two-thirds of the cases of GBS emerge from viral or bacterial infection.
Rawshan Ara Khanam, Mohammad Omar Faruq, Rawshan Ali Basunia, ASM Areef Ahsan   +3 more
openaire   +3 more sources

Diagnosis and management of Guillain–Barré syndrome in ten steps

Nature Reviews Neurology, 2019
Guillain–Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases,
S. Leonhard, Melissa R. Mandarakas, F. Gondim, K. Bateman, M. L. B. Ferreira, D. Cornblath, P. V. van Doorn, M. Dourado, R. Hughes, Badrul Islam, S. Kusunoki, C. Pardo, R. Reisin, J. Sejvar, N. Shahrizaila, C. Soares, T. Umapathi, Yuzhong Wang, E. Yiu, H. Willison, B. Jacobs   +20 more
semanticscholar   +1 more source

Guillain-Barre syndrome in 220 patients with COVID-19

The Egyptian Journal of Neurology Psychiatry and Neurosurgery, 2021
This review summarises and discusses recent findings concerning the pathophysiology, clinical presentation, diagnosis, treatment, and outcome of SARS-CoV-2-associated Guillain-Barre syndrome (SC2-GBS).
J. Finsterer, F. Scorza
semanticscholar   +1 more source

Clinical Profile, Functional Outcome, and Mortality of Guillain-Barre Syndrome: A Five-Year Tertiary Care Experience from Nepal

Neurology Research International, 2019
Introduction. Guillain-Barre syndrome is the most common cause of acute flaccid paralysis in the adult population. It occurs at the rate of 0.34 to 4 per 100000 individuals.
Saroj Kumar Bhagat, Shrey Sidhant, Mukesh Bhatta, Ashish Ghimire, Bhupendra Shah   +4 more
doaj   +1 more source

Reversible stress cardiomyopathy in Guillain-Barré syndrome: a case report

Journal of Medical Case Reports, 2019
Background Guillain-Barré syndrome is an autoimmune disorder in which autoantibodies mainly affect the peripheral nervous system. Autonomic dysfunction is a common and severe complication of Guillain-Barré syndrome.
A. Gravos, A. Destounis, K. Katsifa, P. Tselioti, K. Sakellaridis, V. Grammatikopoulou, C. Tsapas, A. Nodarou, P. Batiani, A. Prekates   +9 more
doaj   +1 more source

Guillain–Barré syndrome in low-income and middle-income countries: challenges and prospects

Nature Reviews Neurology, 2021
The epidemiology, clinical characteristics, management and outcome of Guillain–Barré syndrome (GBS) differ between low-income and middle-income countries (LMIC) and high-income countries (HIC).
Nowshin Papri, Z. Islam, S. Leonhard, Q. Mohammad, H. Endtz, B. Jacobs   +5 more
semanticscholar   +1 more source

Concomitant Guillain–Barré Syndrome in a young Sri Lankan male with severe ulcerative colitis

BMC Gastroenterology, 2022
Background Guillain–Barré Syndrome is an immune mediated polyneuropathy. Ulcerative Colitis is an immune mediated chronic inflammatory condition mainly of the large intestine. Guillain–Barré Syndrome can present as a rare extraintestinal manifestation of
Jayasundara Mudiyanselage Hishali Dahami Jayasundara, Vajira Tharanga Samarawickrama, Ranjith Peiris, Tilan Aponso, Danushi Abeynayake   +4 more
doaj   +1 more source

Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.

JAMA Internal Medicine, 2021
Importance Guillain-Barré syndrome can be reported after vaccination. This study assesses the risk of Guillain-Barré syndrome after administration of recombinant zoster vaccine (RZV or Shingrix), which is administered in 2 doses 2 to 6 months apart ...
Ravi Goud, Bradley Lufkin, J. Duffy, B. Whitaker, H. Wong, Jiemin Liao, A. Lo, Shruti Parulekar, P. Agger, S. Anderson, M. Wernecke, T. MaCurdy, Eric S. Weintraub, J. Kelman, R. Forshee   +14 more
semanticscholar   +1 more source

Incidence rates of Guillain Barré (GBS), chronic fatigue/systemic exertion intolerance disease (CFS/SEID) and postural orthostatic tachycardia syndrome (POTS) prior to introduction of human papilloma virus (HPV) vaccination among adolescent girls in Finland, 2002–2012

Papillomavirus Research, 2017
In Finland a vaccination programme against human papillomavirus (HPV) was introduced in November 2013 for girls aged 11-12 years with a catchup for girls 13-15 years. Allegations that HPV vaccine is causing Guillain Barré syndrome (GBS) and non-specific diagnostic entities, such as chronic fatigue syndrome/systemic exertion intolerance disease (CFS ...
J. Skufca, J. Ollgren, E. Ruokokoski, O. Lyytikäinen, H. Nohynek   +4 more
openaire   +3 more sources